Advanced Search

 

Study ID Status Title Patient Level Data
204654 Recruiting Protocol to Characterize Severe Asthma Patient Experience of Treatment Benefit with an anti-IL5 with Clinical Trial Exit Interviews
204661 Completed PGx7612: Pharmacogenetic investigation of the association of the ADRB2 rare variant, Thr164Ile with severe asthma exacerbation
204663 Completed An exploratory study to assess the effect of topical application of Iodex® balm on local surface temperature using infra red thermal imaging technique
204664 Completed Meta-Analysis in sponsored studies MEA112997, MEA115588, and MEA115575 and a proof of concept investigator sponsored study CRT110184 of Mepolizumab in Severe Asthma
204674 Recruiting An open label, multi-centre, post marketing surveillance (PMS) to monitor the safety and effectiveness of RELVAR administered in Korean subjects in usual practice.
204676 Completed A Study to Evaluate the Effects of Protein Supplementation in Attenuating the Decline in Performance Following Strenuous Concurrent Exercise
204676 Completed A Study to Evaluate the Effects of Protein Supplementation in Attenuating the Decline in Performance Following Strenuous Concurrent Exercise
204682 Terminated An Open-label Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Subjects with Type 2 Diabetes Mellitus
204699 Completed A randomized double-blind (sponsor unblind) placebo controlled study in healthy subjects to evaluate: safety, tolerability, pharmacokinetics, and pharmacodynamics of the repeat doses of GSK2881078, the Selective Androgen Receptor Modulator with an open label dosing arm to evaluate the effect of CYP3A4 inhibition on pharmacokinetics of GSK2881078
204725 Completed An Open Label, Randomized, Single Dose, Crossover study to determine the Pharmacokinetics of Three Tablet Formulations of GSK2798745 in Healthy Subjects
204729 Completed A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Ascending Dose Escalating, 4 Period Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of Single Doses of GSK3179106, a REarranged during Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Normal Healthy Volunteers
204736 Completed Sun Protection Factor Determination (In vivo determination of the sun protection factor ISO 24444) (61-SPF-iM)
204738 Completed The effects of 2 consecutive days of multiple highintensity exercise bouts on cognitive function, mood and fatigue state in well-trained intermittent sports players.
204738 Completed The effects of 2 consecutive days of multiple highintensity exercise bouts on cognitive function, mood and fatigue state in well-trained intermittent sports players.
204739 Completed Study to investigate the initial stages of enamel erosion in vivo
204749 Completed Heat, eat, compete: Investigating the application of localised heating on muscle glycogen
204749 Completed Heat, eat, compete: Investigating the application of localised heating on muscle glycogen
204762 Completed A Clinical Study Investigating the Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief from Dentinal Hypersensitivity
204763 Completed A Clinical Study Investigating the Efficacy of Two Experimental Oral rinses in Providing Long Term Relief from Dentinal Hypersensitivity
204764 Completed Determination of UVA Protection Factor (UVAPF) for a cosmetic product
204767 Completed Determination of UVA Protection Factor (UVAPF) for a cosmetic product
204768 Completed Determination of UVA Protection Factor (UVAPF) for a cosmetic product
204769 Completed Determination of UVA Protection Factor (UVAPF) for a cosmetic product
204771 Completed Determination of UVA Protection Factor (UVAPF) for a cosmetic product
204773 Completed A Clinical Study Investigating the Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief from Dentinal Hypersensitivity

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.